Advertisement Datatrak, Specialty Biotech enter multi-year deal - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Datatrak, Specialty Biotech enter multi-year deal

Datatrak International, a global provider of eClinical solutions for the clinical trials industry has signed a multi-year Enterprise Agreement with specialty biologics and vaccines company.

The vaccine company will utilize the Datatrak one unified software suite to conduct a series of trials.

Datatrak CEO Laurence P Birch said the input of the specialty biologics company into the growth of their products would be invaluable.

"Signing another Enterprise client demonstrates the commitment to Datatrak’s unified product suite and exemplifies the industry’s need for a single solution to conducting clinical trials from Concept to Cure," Birch added.